Introducing IMD’s newest content partner the Canadian Alopecia Areata Foundation 

Canadian Alopecia Areata Foundation and IMD Health Global announce strategic partnership to provide educational resources on alopecia to care providers, patients, and their families

April 12, 2022 – King City, ON

IMD Health Global (IMD) is proud to announce a meaningful partnership with the Canadian Alopecia Areata Foundation (CANAAF). IMD is a CloudMD Software & Services company focused on health education, providing engaging and informative resources to healthcare providers, patients, and caregivers via the IMD Health Patient Engagement Platform.  

“CANAAF’s partnership with IMD Health will allow us to ensure that our vital resources reach healthcare providers and Alopecia Areata patients across the country,” said Anthony Gilding, Canadian Alopecia Areata Foundation’s Director of Science and Research. “This collaboration will be a major step in better educating folks on the disease and its impact on patients’ lives.”

IMD Health is the largest digital health education platform in Canada, and one of the largest in North America. CANAAF is IMD’s newest health content partner, joining over 100 Canadian and American health organizations that have partnered with the platform. This new partner will help facilitate conversations between healthcare professionals and patients with alopecia areata.  

“We are very excited to collaborate with the Canadian Alopecia Areata Foundation to provide clinicians, patients, and their families helpful materials about alopecia areata,” said Blaise O’Malley, Medical Content Manager, IMD. “CANAAF contributes greatly to the national alopecia areata community, and we look forward to working with them.”  

To explore CANAAF’s content on IMD, click here: https://app.imdhealth.com/topic/8bde151a-ee7c-47da-89ff-b2ae794fe3f4/b3bad0b0-3bcf-46b6-9b2b-1c93b1280a2b

About the Canadian Alopecia Areata Foundation

The Canadian Alopecia Areata Foundation (CANAAF) was founded in 2009 and is the largest patient organization in Canada for families with Alopecia Areata. CANAAF’s leadership understands the deep impact of alopecia areata and provides resources to support psychosocial health, educate and raise awareness of this autoimmune disease, and raises funds for current research.

 Learn more at https://www.canaaf.org/

For additional information, contact: Anthony Gilding, Director of Science and Research, at science@canaaf.org

About IMD Health Global

IMD Health Global is a Toronto-based eHealth company, focused on innovating healthcare education.  Since 2010, IMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care” ®, healthcare professionals use IMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 110,000 images, booklets, and video resources (covering over 6,000 health topics) into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and treatment plan adherence. The IMD platform is utilized by over 16,000 practitioners (doctors, nurses, and pharmacists) in clinics, hospitals, pharmacies, infusion clinics, and homecare settings.  For more information please visit: www.IMDhealth.com and https://app.IMDhealth.com      IMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC)

For more information, contact: Jared Sonnenberg   jared.sonnenberg@IMDhealth.com

About CloudMD Software & Services

CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.

CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America. For more information visit: https://investors.cloudmd.ca